Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats

被引:38
作者
Hao, JX
Xu, XJ
Urban, L
Wiesenfeld-Hallin, Z [1 ]
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Div Clin Neurophysiol, Dept Med Lab Sci & Technol, SE-14186 Huddinge, Sweden
[2] Novartis Inst Med Sci, London, England
关键词
analgesia; central pain; neuropathic pain;
D O I
10.1016/S0304-3940(00)00787-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effect of systemic gabapentin, a novel antiepileptic and analgesic, was tested on allodynia-like behaviors in spinal cord injured rats. On the first day of treatment 30 mg/kg intraperitoneal gabapentin did not alleviate hyper-reactivity to mechanical and cold stimulation. The allodynia was significantly reduced by 100 mg/kg gabapentin, which however, produced sedation and motor impairments. Repeated administration of 30 mg/kg gabapentin once a day produced a gradually increasing anti-allodynic effect. Total alleviation of mechanical allodynia was observed in most rats after the third administration of gabapentin. Thus, build-up of the antiallodynic effect of gabapentin may develop through a time dependent mechanism or alternatively through a gradual accumulation of the effective central nervous system concentration of the drug. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 20 条
[1]   The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain [J].
Abdi, S ;
Lee, DH ;
Chung, JM .
ANESTHESIA AND ANALGESIA, 1998, 87 (06) :1360-1366
[2]   Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: A pilot study [J].
Attal, N ;
Brasseur, L ;
Parker, F ;
Chauvin, M ;
Bouhassira, D .
EUROPEAN NEUROLOGY, 1998, 40 (04) :191-200
[3]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[4]   Identification of novel ligands for the gabapentin binding site on the α2δ subunit of a calcium channel and their evaluation as anticonvulsant agents [J].
Bryans, JS ;
Davies, N ;
Gee, NS ;
Dissanayake, VUK ;
Ratcliffe, GS ;
Horwell, DC ;
Kneen, CO ;
Morrell, AI ;
Oles, RJ ;
O'Toole, JC ;
Perkins, GM ;
Singh, L ;
Suman-Chauhan, N ;
O'Neill, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) :1838-1845
[5]   Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents [J].
Field, MJ ;
Oles, RJ ;
Lewis, AS ;
McCleary, S ;
Hughes, J ;
Singh, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) :1513-1522
[6]   Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, an immunotherapeutic drug [J].
Gillin, S ;
Sorkin, LS .
ANESTHESIA AND ANALGESIA, 1998, 86 (01) :111-116
[7]  
Hao JX, 1996, PAIN, V66, P279
[8]   The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain [J].
Hunter, JC ;
Gogas, KR ;
Hedley, LR ;
Jacobson, LO ;
Kassotakis, L ;
Thompson, J ;
Fontana, DJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 324 (2-3) :153-160
[9]  
Pan HL, 1999, J PHARMACOL EXP THER, V288, P1026
[10]  
RADULOVIC LL, 1995, DRUG METAB DISPOS, V23, P441